Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose Dexamethasone
Open Access
- 28 August 2003
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 349 (9), 831-836
- https://doi.org/10.1056/nejmoa030254
Abstract
The role of high-dose dexamethasone in the treatment of immune thrombocytopenic purpura in adults is controversial. We assessed the effectiveness of high-dose dexamethasone as initial treatment in a series of consecutive adults with immune thrombocytopenic purpura.Keywords
This publication has 17 references indexed in Scilit:
- Immune Thrombocytopenic PurpuraThe New England Journal of Medicine, 2002
- Initial management of adults with idiopathic (immune) thrombocytopenic purpuraBlood Reviews, 2002
- Pulsed Intravenous High-Dose Dexamethasone in Adults with Chronic Idiopathic Thrombocytopenic PurpuraBlood Cells, Molecules, and Diseases, 2000
- High-Dose Pulsed Dexamethasone for Immune ThrombocytopeniaThe New England Journal of Medicine, 1997
- Failure of pulse high-dose dexamethasone in chronic idiopathic immune thrombocytopeniaAmerican Journal of Hematology, 1997
- Pulsed high‐dose dexamethasone in refractory chronic idiopathic thrombocytopenic purpura: a report on 10 casesBritish Journal of Haematology, 1995
- Long-Term observation of 208 adults with chronic idiopathic thrombocytopenic purpuraAmerican Journal Of Medicine, 1995
- Chronic Idiopathic Thrombocytopenic PurpuraThe New England Journal of Medicine, 1994
- Response of Resistant Idiopathic Thrombocytopenic Purpura to Pulsed High-Dose Dexamethasone TherapyThe New England Journal of Medicine, 1994
- MANAGEMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTSBritish Journal of Haematology, 1985